CORBEL Catalogue of Services


Why do we need a Catalogue of Services?

Currently there are 13 biological and medical sciences Research Infrastructures (RIs) in Europe, all of them working jointly together in CORBEL towards offering shared services for life-science.
All RIs offer services, i.e. researchers from academia and industry can access their facilities, technologies and expertise. Services can simply be consultation, access to experts, but also access to data and biological samples, use of data analysis tools, access to facilities (e.g. highly specialised microscopes) plus support from technicians and much more.

The CORBEL Catalogue of Services is the first tool to list the main services of all these RIs at a glance and it aims to facilitate the utilisation of RI services by researchers from all over the world.

The Catalogue of Services as displayed below aims to provide you a basic overview on existing services within distinct thematic fields.
You can either use the Catalogue of Services to identify a single RI to help you with your work or you can create your own CORBEL service pipelines, i.e. using several RIs subsequently.

Examples of service pipelines are provided here. 

>> In order to improve the catalogue, we kindly ask you to fill in a short feedback form.
     Many thanks!

What’s your need?

Please select…



Contact person(s): Florence Guillot

The European Marine Biological Research Centre (EMBRC) is a Research Infrastructure including 24 Operators across 9 different European countries. EMBRC is dedicated for marine biology and ecology research. EMBRC is offering to the scientific community, academic institutions and private companies a comprehensive set of services to study marine organisms and to give access to ecosystems. EMBRC is providing local or remote access to state-of-the-art national facilities such as renowned marine biological stations.

Services provided

The EMBRC service offer includes

  • access to ecosystems: coastal research vessels, scientific diving facilities, submersibles (ROV/AUV), in-situ sampling facilities and monitoring equipment, field stations
  • marine biological resources (micro & macro, alive & fixed, wild & cultivated): biobanks, culture collections (algae, bacteria, zooplankton... within RCC, MOLA, PCC, MCCV), marine model organisms, sampling upon request
  • experimental facilities: aquaria & mesocosms, wet and dry laboratories, climate rooms, field experiment
  • technology platforms: aquaculture, biological analysis, imaging, molecular biology and ‘omics, remote sensing and telemetry, structural and chemical analysis
  • e-Infrastructure, data & services: data, data analysis tools and softwares, computing and storage infrastructure, bioinformatics and data management services

Costs depend on the nature of the requested service.
Researchers can apply for funding from EMBRC to access it services, Open Calls are posted on the EMBRC website.
For further information please contact us.

Access modes

Through the 24 European operators, the user can access to the services remotelly or on-site. The user has to select the service of interest first and he/she will be redirected to the national website of the operator where detailed information are provided.

Why to work with us

Researchers should work with us in order to have access to marine ecosystems, marine biological resources and associated technological platforms for analysis.

Countries involved




Contact person(s): Dr. Roland Pieruschka, Dr. Sven Fahrner

EMPHASIS is a pan-European distributed plant phenotyping infrastructure project. EMPHASIS will focus on developing and enabling access to plant phenotyping infrastructure and provision of services, essential for the analysis of crop performance with respect to structure, function, quality and interaction with the environment. It will thus support the exploitation of crop genetic diversity required for the enhancement of plant productivity and progress in plant breeding.

Services provided

In cooperation with EPPN2020, EMPHASIS offers access to plant phenotyping infrastructures, this includes

  • high-throughput facilities
  • lean field facilities
  • intensive field facilities
  • assay development
  • data management

Further services are currently under development and will be implemented in its operational phase.

The access provided currently via EPPN2020 is free of charge for selected user-groups, based on a simple application procedure and includes the logistical, technological and scientific support as well as specific training required to successfully complete the approved Transnational Access project.
For further information please contact us.

Access modes

European-wide access to plant phenotyping infrastructures is currently under development in our partner project EPPN2020 and will provided via its homepage.
Access will be accordingly provided by EMPHASIS once it reaches its operational phase.

Why to work with us

EPPN2020 provides Transnational Access to plant phenotyping infrastructure as a basis for novel scientific approaches to quantitative plant assessment in high thoughput. The installations represent a diverse set of facilities for plant phenotyping in Europe with focus on: i) no-invasive high throughput phenotyping under controlled conditions, ii) destructive sampling aiming at assessing underlying traits helping to understand the genetic variability of different plant processes, iii) controlled field facilities allowing users to control rainfall and/or the concentration of air CO2 together with high-definition non-invasive sensors. Transnational Access will be available based on a simple and transparent access procedure.

Countries involved

Preparatory Phase of the project: BE, FR, IT, NL, UK, DE



Contact person(s): Dr. Hervé Raoul, Diana Stepanyan-Yerdamian

European Research infrastructure on Highly Pathogenic Agents (ERINHA) is set up to reinforce the European capacities for the study of high consequence pathogens (e.g. Ebola, Lassa, Nipah etc.) and enhance the coordination of Biosafety level 4 and supporting infrastructures. It provides a world-leading high containment capacities and unique expertise and gives access to all interested relevant scientists with large scale research programmes. ERINHA as a legal entity operates as an AISBL - International non-profit Association under Belgian law. It started its implementation phase from July 2017.

Services provided

The services offered by ERINHA include

  • access to state of art European high containment facilities and high consequence pathogens expertise (BSL 4 and connecting infrastructures) to perform research activities (cutting-edge technologies and functions to perform excellence oriented research: e.g. epi-fluorescence microscopes, automate for animal biological analysis, cytometry, laminar BSC etc.)
  • project coordination and management of large scale research programmes on high consequence pathogens
  • training for potential users
  • advice and scientific expertise provider: RG4 pathogens research, containment facilities construction, biosafety/biosecurity issues, sample transport etc.
  • access to pathogens specimens

Costs for offered services are currently under reevaluation.
For further information please contact us.

Access modes

The ERINHA's Central Coordination Unit ensures access to the RI services. Projects can be submitted by academic, public and industrial users. Projects will be selected based on the scientific excellence and should match with ERINHA's scientific strategy.

Why to work with us

The 2014-2015 Ebola outbreak and cases in Europe demonstrated the worldwide vulnerability and need for common action putting together rare high containment capacities and expertise to be able to increase European and global preparedness for outbreaks of high consequence pathogens. ERINHA facilitates access to required infrastructure capacities thanks to its CCU and multiple high containment and complementary European resources. It is a unique coordinated infrastrucuture providing transnational access to its facilities, large scope of services and shorter delays in access.

Countries involved

Upcoming members: HU, GR



Contact person(s): Dr. Katja Herzog, Dr. Bahne Stechmann

EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe, which jointly use a rationally selected compound collection, comprising up to 140.000 commercial and proprietary compounds collected from European chemists. EU-OPENSCREEN offers to researchers from academic institutions, SMEs and industrial organisations open access to its shared resources.

EU-OPENSCREEN will collaboratively develop novel molecular tool compounds with external users from various disciplines of the life sciences.

Services provided

Services provided by EU-OPENSCREEN include

  • high-throughput compound/ drug screening (HTS): HTS of an assay against the EU-OPENSCREEN chemical collection (> 100,000 compounds); in silico profiling; hit selection; confirmatory screening; basic counter screening; basic SAR based on screening data; QC of confirmed hits
  • access to a unique European compound collection: EU-OPENSCREEN chemical collection (> 100,000 compounds)
  • assay adaption: This assay adaptation process will involve a strong emphasis on quality, including: quality control of reagents; (patho-)physiological relevance; pharmacological consistency; robustness; minimised variability; and tracking of statistical descriptors 
  • chemical optimization and profiling of preliminary ‘hits’
  • bioprofiling of donated compounds: All compounds donated by the user which enter the EU-OPENSCREEN ERIC compound collection are characterised and annotated for basic physico-chemical (e.g. identity, solubility, light absorbance and fluorescence) and essential to know biological properties (cytotoxicity, antibiotic, antifungal etc.) by testing in a standard panel of assays.
  • provision of standardised data: All data generated through QC/bioprofiling and screening activities will be published in EU-OPENSCREEN’s open-access database with an optional ‘grace’ period (i.e. delayed publication of data). Large-scale open-access data provide the basis for computational data integration to obtain a systematic view, allow for prediction of drug-target interactions and networks as well as of adverse effects and drug combinations. The access to the EU-OPENSCREEN database will utilize the facilities of ChEMBL.
  • training and education

A screening project at a typical EU-OPENSCREEN screening site will cost 50-250k €, strongly depending on the number of screened substances and the maturity/ complexity of the assay.
A compound replenishment fee structure applies to all projects using the EU-OPENSCREEN compound collection and users from countries which are members of the EU-OPENSCREEN ERIC will receive a discount on this cost.
For further information please contact us.

Access modes

Users are requested to submit project proposal to the EU-OPENSCREEN office. Depending on the project requirements, the RI can be assessed remotely or on-site.

Why to work with us

The majority of scientists in Europe do not have access to suitable technology platforms and compound collections, which are generally expensive to purchase, operate and maintain. As a large-scale research infrastructure (RI) with an ‘open’ pre-competitive character, EU-OPENSCREEN will cost-effectively overcome this limitation by: involving and providing access to Europe’s leading screening platforms and chemistry groups; offering a jointly used rationally designed compound collection; and operating an open-access bioactivity database which will be accessible on a global basis. EU-OPENSCREEN offers to support you through grant application processes and beyond for funding involving screening projects.

Countries involved




Contact person(s): application, biological imaging, medical imaging

Euro-BioImaging (EuBI) provides open physical user access to a broad range of state-of-the-art imaging technologies for life scientists in Europe and beyond. In the future, it also will offer image data support and training for infrastructure users and providers and continuously evaluate and include new imaging technologies to ensure cutting-edge services in a sustainable manner.

Through Euro-BioImaging (EuBI), researchers can have access to imaging instruments, receive expert technical assistance and support both with project planning and during project execution. In the future, EuBI will offer image data support and training for infrastructure users and providers. Since May 2016, EuBI has opened its doors to the scientific community with the start of Interim Operation. This means that all researchers at any stage of their career can now request access to 36 imaging technologies hosted at 28 EuBI Node Candidates (specialized imaging facilities hosting the technology and expertise) located in 11 European countries and at EMBL.

Services provided

Please visit the EuBI Web Access Portal for more information about the offered imaging technologies as listed below:

  • biological Imaging: Laser scanning confocal microscopy (LSCM / CLSM), Spinning disc confocal microscopy (SDCM), Deconvolution widefield microscopy, Multiphoton microscopy systems, Total internal reflection fluorescence microscopy (TIRF), Fourier transform infrared imaging (FTIR)
  • super resolution microscopy: Stimulated emission depletion microscopy (STED), Photo activated localization microscopy (PALM), Stochastic optical reconstruction microscopy (STORM), Reversible saturable optical fluorescence transitions (RESOLFT), Ground state depletion microscopy (GSD) / Ground state depletion microscopy followed by individual molecule return (GSDIM), 4Pi microscopy
  • functional imaging: Fluorescence correlation spectroscopy (FCS), Fluorescence cross-correlation spectroscopy (FCCS), Fluorescence-lifetime imaging microscopy (FLIM), Fluorescence resonance energy transfer (FRET), Fluorescence recovery after photobleaching (FRAP), Raman spectroscopy, High-throughput microscopy, Electron microscopy, Correlative light electron microscopy (CLEM)
  • mesoscopic imaging: Objective-coupled planar illumination (OCPI), Selective plane illumination microscopy (SPIM), Optical projection tomography (OPT), Digital scanned laser light-sheet fluorescence microscopy (DSLM)
  • multi-modal molecular imaging: (Micro)-PET, (Micro)-SPECT, (Micro)-MRI/MRS, (Micro)-CT, (Micro)-US, (Micro)-PET/CT, (Micro)SPECT/CT, Optical imaging
    Note: The "micro" prefix in brackets before the name of a technology, e.g. (micro)-MRI, indicates that imaging equipment and set-up optimized for both large and small animals are available.
  • medical imaging: High-Field MRI, Phase contrast imaging, Multimodal Imaging (MRI-PET), Population Imaging
  • data management

The access fees for each visit are individually discussed and agreed upon directly between the EuBI user and the respective EuBI Node Candidate as part of the pre-visit discussion during the project planning phase. Thereby, the user is fully informed and aware of all costs that will arise related to the access to a EuBI Node Candidate. The EuBI Hub Candidates, taking care of all administrative work in EuBI, do not charge any costs to the users!
EuBI users can be supported by funded access programs such as iNEXT. Further funding opportunities will be announced on the website.

Access modes

EuBI offers open access to its technology portfolio, which is put in place using a selection procedure based on scientific soundness and technical feasibility of the project. In most cases, scientists visit the requested Node Candidate to perform their experiments on-site, being supported throughout their project by expert technical staff. Access to the Image Data Resource is remote and online via the EuBI website and directly.

Why to work with us

For many researchers coming from various scientific fields, access to high-end imaging technologies is a big plus and provides substantial advantage for their research. Life-cell imaging, electron microscopy and medical imaging, multi-modal molecular imaging, high-throughput or super-resolution microscopy – there are plenty of technologies at Euro-BioImaging that can be exploited.
After a simple and straightforward application process, your project proposal is evaluated based on its scientific merit and its technical feasibility. After approximately three weeks, you will receive the result of this evaluation process, and, if successful, you are invited to immediately start planning your visit to your requested imaging facility – the so called EuBI Node Candidate - together with highly trained staff working in this facility. Throughout all project phases, from the planning to the execution and the data analysis, you can profit from the expert support provided by the Node Candidates.

Countries involved

Member countries in the Interim Board: AT, BE, BG, CZ, ES, FI, FR, HU, IL, IT, NL, NO, PL, PT, SK, UK, EMBL

Observer: DK, DFG (representing the Alliance of Science Organisations in Germany), SE



Contact person(s): Dr. Claudia Alen Amaro

Instruct-ERIC is a pan-European research infrastructure in structural biology, making high-end technologies and methods available to scientists. Access is provided free for academic scientists at Instruct centres and includes expert support.

Services provided

Services offered by Instruct include

  • structural analysis: Electron Microscopy (including CryoEM), Nuclear Magnetic Resonance (Solution and Solid State NMR), X-Ray crystallography Beamline;
  • biophysical characterisation: Proteomic Mass Spectrometry, Surface Plasmon Resonance;
  • sample preparation: Bacterial/Baculovirus/Mammalian/Yeast/Cell-Free expression, Nanobody Production, Crystallisation;
  • data analysis: Image Processesing, Bioinformatics

Free for academic users; on service-basis for commercial use (user access is on a fee for service basis; no obligation to disclose or publish data).
Users can apply for travel and accommodation costs where a physical visit to an Instruct facility is required.
For further information please contact us.

Access modes

Dependent on the requested service, access can be on-site, remote, mail-in sample.
For further information please contact us.

Why to work with us

Instruct is at the cutting edge of new technologies: automation, remote access, new detector methods, advanced imaging. Access to Instruct-ERIC infrastructure can help advance your research - 443 peer reviewed scientific publications ackowledge Instruct.

Countries involved




Contact person(s): MIRRI Interim Secretariat

MIRRI is the pan-European research infrastructure for microbial resources [i.e. bacteria (including cyanobacteria), archaea, fungi, yeasts, plant viruses, bacteriophages and their isolated DNA]. In addition, the MIRRI repertoire also covers human, animal and plant cell cultures.

By provision of high quality microorganisms, associated data and the broad expertise of our partners, MIRRI aims to support research and development in the field of biotechnology.

Services provided

MIRRI services comprise

  • access to microorganisms/cell lines deposited in public collections
  • deposit of microorganisms/cell lines (public collection/patents)
  • phenotypic/molecular characterisation of microorganisms
  • identification/molecular typing of microorganisms
  • isolation/cultivation/preservation of microorganisms
  • microbial community analyses
  • microbial phylogenetic studies
  • screening/bioassays with microorganisms
  • access to microbiological databases
  • consultancy/contract research
  • legal issues (e.g. Nagoya Protocol)
  • biosafety/biosecurity
  • training

Costs depend on the kind of service requested.
For further information please contact us.

Access modes

Access modes depend on the kind of service requested.
For further information please contact us.

Why to work with us

MIRRI offers not only a broad spectrum of high quality microorganisms, but also a longlasting expertise in each field of microbiology. Aiming at harmonising the current microbial Biological Resource Centre (mBRC) landscape, MIRRI enables facilitated access to deposited microorganisms and is constantly improving the corresponding state-of-the-art service offers. Our experts ensure legal compliance of resources (Nagoya Protocol) and with the envisaged interoperability of existing and future databases researchers can exploit the full value of microorganisms.

Countries involved

under development

Please note: Most of the RIs are constantly developing their portfolio of services, so if you do not find the service/tool you are looking for, do not hesitate to contact the RI and ask for it!

This project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654248.


left to apply to the final Open Call submission round –
don’t miss this last chance! »

Open Call